Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Treasury Shares (2019 - 2021)

IDEAYA Biosciences (IDYA) has disclosed Treasury Shares for 3 consecutive years, with $7313.0 as the latest value for Q1 2021.

  • Quarterly Treasury Shares fell 50.0% to $7313.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $7313.0 through Mar 2021, down 50.0% year-over-year, with the annual reading at $10518.0 for FY2020, 55.62% down from the prior year.
  • Treasury Shares hit $7313.0 in Q1 2021 for IDEAYA Biosciences, down from $10518.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $23698.0 in Q4 2019 to a low of $5169.0 in Q2 2020.
  • Historically, Treasury Shares has averaged $12327.8 across 3 years, with a median of $11200.0 in 2019.
  • Biggest YoY gain for Treasury Shares was 29.4% in 2020; the steepest drop was 56.5% in 2020.
  • Year by year, Treasury Shares stood at $23698.0 in 2019, then tumbled by 55.62% to $10518.0 in 2020, then crashed by 30.47% to $7313.0 in 2021.
  • Business Quant data shows Treasury Shares for IDYA at $7313.0 in Q1 2021, $10518.0 in Q4 2020, and $10518.0 in Q3 2020.